NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 77 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 176 | -99.6% | 0.00% | – |
| Q1 2022 | $88,000 | +417.6% | 47,292 | +1204.2% | 0.00% | – |
| Q4 2021 | $17,000 | +1600.0% | 3,626 | +3526.0% | 0.00% | – |
| Q1 2021 | $1,000 | -87.5% | 100 | -83.5% | 0.00% | – |
| Q4 2020 | $8,000 | -20.0% | 605 | -33.5% | 0.00% | – |
| Q3 2020 | $10,000 | +11.1% | 910 | +9.0% | 0.00% | – |
| Q1 2020 | $9,000 | +200.0% | 835 | -22.8% | 0.00% | – |
| Q3 2019 | $3,000 | – | 1,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,156,200 | $10,672,000 | 1.77% |
| ACT CAPITAL MANAGEMENT, LLC | 239,000 | $2,207,000 | 1.13% |
| EcoR1 Capital, LLC | 2,358,804 | $21,772,000 | 0.81% |
| Redmile Group, LLC | 3,919,235 | $36,175,000 | 0.54% |
| Boxer Capital, LLC | 1,501,058 | $13,855,000 | 0.49% |
| Baker Brothers Advisors | 3,821,740 | $35,275,000 | 0.16% |
| Sio Capital Management, LLC | 38,312 | $354,000 | 0.09% |
| Highland Private Wealth Management | 46,999 | $434,000 | 0.06% |
| PERSONAL CFO SOLUTIONS, LLC | 23,710 | $219,000 | 0.04% |
| Point72 Asset Management, L.P. | 883,102 | $8,151,000 | 0.04% |